CAS: 1005264-47-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MX-69 REF: IN-DA0096EHCAS: 1005264-47-0 | 98.0% | To inquire | Wed 04 Dec 24 |
 | MX-69 REF: 3B-M3570CAS: 1005264-47-0 | >98.0%(T)(HPLC) | 167.00 € | Tue 10 Dec 24 |
 | MX69 REF: TM-T3653CAS: 1005264-47-0 | 97.27% - 99.57% | 36.00 €~1,170.00 € | Wed 11 Dec 24 |
 | MX69 REF: 3D-FQB26447CAS: 1005264-47-0 | Min. 95% | To inquire | Wed 15 Jan 25 |
Ref: IN-DA0096EH
| 10mg | 326.00 € | ||
| 25mg | 626.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
MX-69
CAS:1005264-47-0
Formula:
C27H26N2O4S
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
474.58
Ref: 3B-M3570
| 25mg | 167.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
MX69
CAS:1005264-47-0
MX69 is the MDM2/XIAP inhibitor, blocking the MDM2 protein-XIAP RNA interaction, leading to MDM2 degradation.
Formula:
C27H26N2O4S
Purity:
97.27% - 99.57%
Color and Shape:
Solid
Molecular weight:
474.57
Ref: TM-T3653
| 1mg | 36.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 225.00 € | ||
| 50mg | 363.00 € | ||
| 100mg | 541.00 € | ||
| 500mg | 1,170.00 € | ||
| 1mL*10mM (DMSO) | 82.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
MX69
CAS:1005264-47-0
MX69 is a compound that inhibits the BCL-2 protein. It was developed as an anti-cancer …
Formula:
C27H26N2O4S
Purity:
Min. 95%
Molecular weight:
474.57 g/mol
Ref: 3D-FQB26447
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
